Particle Universe
AI for Science Research
Life Science
Materials Science
Lebesgue Intelligent Computing
About Us
中文
RiDYMO®
an AI for Science-Driven Hit Discovery Platform
Unlocking Dynamics of Challenging Targets and Exploring Vast Chemical Space of Macrocycles and Small Molecules with Physics
CONTACT SALES
bd@dp.tech
bd@dp.tech
End-to-End Hit Discovery
Our mission is to revolutionize drug discovery by leveraging AI, physics, and automation to tackle challenging drug targets, including intracellular PPIs for oral molecules. By exploring the vast chemical space and elucidating target dynamics, we aim to rapidly synthesize and deliver innovative small molecules and macrocycles that transcend traditional boundaries, ultimately addressing unmet medical needs.
Target Structure and Dynamics
Breaking through traditional targets
Unlock your program for rigorous structure and dynamics-based design
Protein dynamics and discovery of cryptic binding sites
Hit Discovery
Vast chemical space
Discover a wider range of diverse small molecules and macrocycles
Customized Molecular Libraries
Robust Design and Screening Methodologies
Synthesis
Rapidly synthesis and delivery
In Vitro Experiments
DP Wet Lab specializes in developing cell biology assays for hit and lead compound screening, confirmation, and further validation. By fusing AI, physics-based methods, and real-time experimental feedback, we create a self-improving hit discovery process. This integration allows us to constantly refine our models and design strategies, leading to increasingly high-quality hits over time.
1
Target screening SAR assays
2
Further confirmation assay
3
Commercially available stable cell lines:
